Sort
141,003 grants matching “cytokine”
Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease
$994,162Charles T Roberts · Oregon Health & Science University · R01 · FY2023 · DK
SEXUALLY TRANSMITTED DISEASES COOPERATIVE RESEARCH CENTE
$994,133Boston Medical Center · U19 · FY2000 · AI
Biologic correlatives of chronic GVHD onset
$993,954Stephanie J Lee · Fred Hutchinson Cancer Research Center · U01 · FY2019 · CA
Modulation of Airway Inflammation in Asthma Models
$993,940Boston University Medical Campus · P01 · FY2005 · AI
STING Activators as Therapy for Cancer
$993,879Glen N Barber · Stinginn, Llc · R42 · FY2023 · CA
Enabling risk-based testing through characterization of environmentally-Induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19
$993,529Florence Burleson · · N01 · FY2021 · ES
STING Activators as Therapy for Cancer
$993,220Glen N Barber · Stinginn, Llc · R42 · FY2022 · CA
Trimer Production and Immunogenicity Testing
$993,090John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2014 · AI
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$993,003Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Antimicrobial and Regenerative Treatment for Oral Mucositis
$992,846Shenda Baker · Synedgen, Inc. · R44 · FY2011 · DE
Inhalation Repurposing of An Approved Drug to Treat Severe Asthma
$992,767John Sullivan · Aeon Respire, Inc. · R44 · FY2023 · HL
AUTOIMMUNITY CENTERS OF EXCELLENCE
$992,726Columbia University Health Sciences · U19 · FY2000 · AI
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
$992,724Dashtimoghadam Erfan · Symphony Biosciences, Inc. · R44 · FY2024 · CA
Biomarkers and Pathogenesis of Multiple Sclerosis: From Mouse to Human
$992,711Dorothy Anne Cross · Washington University · P01 · FY2012 · NS
Chronic Kidney Disease in Children (CKiD)
$992,525Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2012 · DK
PITT-MCRC for Rheumatic and Musculoskeletal Diseases
$992,402C Kent Kwoh · University Of Pittsburgh At Pittsburgh · P60 · FY2011 · AR
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
$992,385Teodora Nicola · Alveolus Bio, Inc. · R44 · FY2025 · HL
Regulation of pulmonary inflammation by leukocytes and extracellular matrix
$992,339Steven F Ziegler · Benaroya Research Inst At Virginia Mason · P01 · FY2013 · HL
InflammaGut: a drug-screenable co-culture system using gut-associated lymphocytes and autologous primary human gut epithelium that reports inflammation
$992,302Bill Thelin · Altis Biosystems, Inc. · R44 · FY2022 · TR
Chronic Kidney Disease in Children (CKiD)
$992,223Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2011 · DK
KL4 Surfactant to Mitigate Radiation-Induced Lung Injury
$992,017Robert Segal · Discovery Laboratories, Inc. · R44 · FY2015 · AI
Development of KLS-13019 for Neuropathic Pain
$991,944Douglas Eric Brenneman · Kannalife Sciences, Inc. · R42 · FY2022 · NS
pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads
$991,940Phillip Chan · Cytosorbents, Inc. · R44 · FY2020 · HL
PATHOGENESIS AND PREVENTION OF OSTEOPOROSIS
$991,902University Of Connecticut Sch Of Med/Dnt · P01 · FY2000 · AR
Role of IgG Fc Glycan Composition in Vaccination
$991,876Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2018 · AI